G. Speck

1.1k total citations
20 papers, 813 citations indexed

About

G. Speck is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, G. Speck has authored 20 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 4 papers in Genetics. Recurrent topics in G. Speck's work include Renin-Angiotensin System Studies (10 papers), Receptor Mechanisms and Signaling (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). G. Speck is often cited by papers focused on Renin-Angiotensin System Studies (10 papers), Receptor Mechanisms and Signaling (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). G. Speck collaborates with scholars based in Germany, United States and Sweden. G. Speck's co-authors include Detlev Ganten, Rudolf Hammer, Bernd Disse, K. L. Rominger, Theodore J. Witek, P. Schelling, Hans Fischer, F.W. Birke, H.M. Jennewein and Christopher J. Meade and has published in prestigious journals such as Brain Research, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

G. Speck

20 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Speck Germany	12	323	316	272	225	167	20	813
Quang T. Nguyen Canada	18	306 0.9×	415 1.3×	187 0.7×	354 1.6×	352 2.1×	49	1.1k
Elizabeth P. Faison United States	11	240 0.7×	483 1.5×	194 0.7×	805 3.6×	166 1.0×	15	1.2k
Michiaki Okumura Japan	19	254 0.8×	303 1.0×	81 0.3×	336 1.5×	244 1.5×	41	969
Isabelle Viossat France	16	252 0.8×	197 0.6×	199 0.7×	217 1.0×	131 0.8×	35	805
Rudolf M. Snajdar United States	13	242 0.7×	478 1.5×	132 0.5×	624 2.8×	95 0.6×	22	1.0k
Mariagnes Verosky United States	15	220 0.7×	334 1.1×	81 0.3×	150 0.7×	151 0.9×	51	777
R. K. Türker Türkiye	14	177 0.5×	228 0.7×	63 0.2×	137 0.6×	142 0.9×	64	636
Seigo Fujimoto Japan	16	249 0.8×	248 0.8×	44 0.2×	114 0.5×	79 0.5×	49	599
John L. Szarek United States	17	290 0.9×	181 0.6×	175 0.6×	46 0.2×	195 1.2×	50	694
P. F. Mento United States	16	247 0.8×	189 0.6×	76 0.3×	355 1.6×	34 0.2×	25	639

Countries citing papers authored by G. Speck

Since Specialization

Citations

This map shows the geographic impact of G. Speck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Speck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Speck more than expected).

Fields of papers citing papers by G. Speck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Speck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Speck. The network helps show where G. Speck may publish in the future.

Co-authorship network of co-authors of G. Speck

This figure shows the co-authorship network connecting the top 25 collaborators of G. Speck. A scholar is included among the top collaborators of G. Speck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Speck. G. Speck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Speck, G.. (2012). History and Failure of the Mega-Project 'Frankfurt 21'. Built Environment. 38(1). 103–112. 3 indexed citations

Birke, F.W., et al.. (2001). In Vitro and in Vivo Pharmacological Characterization of BIIL 284, a Novel and Potent Leukotriene B4 Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 297(1). 458–466. 65 indexed citations

Pensler, Jay M., et al.. (2000). Estrogen and Progesterone Receptors in Gynecomastia. Plastic & Reconstructive Surgery. 106(5). 1011–1013. 24 indexed citations

Disse, Bernd, G. Speck, K. L. Rominger, Theodore J. Witek, & Rudolf Hammer. (1999). Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung disease. Life Sciences. 64(6-7). 457–464. 213 indexed citations

Ensinger, Helmut A., Klaus Mendla, G. Speck, & Rudolf Hammer. (1997). Wal 2014 fu: Affinity for muscarinic receptors from rat tissues and for human muscarinic receptors expressed in cho cells and functional efficacy in vitro. Life Sciences. 60(13-14). 1163–1163. 1 indexed citations

Ensinger, Helmut A., et al.. (1997). WAL 2014 FU (talsaclidine): A preferentially neuron activating muscarinic agonist for the treatment of Alzheimer's disease. Drug Development Research. 40(2). 144–157. 12 indexed citations

Disse, Bernd, et al.. (1993). Ba 679 BR, A novel long-acting anticholinergic bronchodilator. Life Sciences. 52(5-6). 537–544. 117 indexed citations

Bönner, Gerd, Th. Unger, Wolfgang Rascher, et al.. (1984). The renal kallikrein-kinin system in spontaneously hypertensive rats. Inflammation Research. 15(3-4). 111–118. 4 indexed citations

Bönner, Gerd, et al.. (1984). Steroid induced changes of the renal kallikrein-kinin system in rats. European Journal of Endocrinology. 107(1). 131–140. 10 indexed citations

10.

Marin-Grez, M., G. Schaechtelin, Gerd Bönner, et al.. (1982). Renal Kallikrein Activity and Urinary Kallikrein Excretion in Rats with Experimental Renal Hypertension. Clinical Science. 63(4). 349–354. 8 indexed citations

11.

Schelling, P., Dieter Meyer, G. Speck, et al.. (1982). A micromethod for the measurement of renin in brain nuclei: Its application in spontaneously hypertensive rats. Neuropharmacology. 21(5). 455–463. 71 indexed citations

12.

Lang, R., U. B. Brückner, B. Kempf, et al.. (1982). Opioid Peptides and Blood Pressure Regulation. Clinical and Experimental Hypertension Part A Theory and Practice. 4(1-2). 249–269. 36 indexed citations

13.

Unger, Th., Robin W. Rockhold, Gerd Bönner, et al.. (1981). Antihypertensive Effects of the Novel Converting-Enzyme Inhibitor YS 980 in Spontaneously Hypertensive Rats. PubMed. 3(1). 121–140. 9 indexed citations

14.

Bönner, Gerd, Wolfgang Rascher, G. Speck, M. Marin-Grez, & F. Gross. (1981). The renal kallikrein-kinin system in Brattleboro rats with hereditary hypothalamic diabetes insipidus. European Journal of Endocrinology. 98(1). 36–42. 7 indexed citations

15.

Ganten, D, G. Speck, P. Schelling, & T Unger. (1981). The brain renin--angiotensin system.. PubMed. 28. 359–72. 11 indexed citations

16.

Speck, G., Knud Poulsen, Th. Unger, et al.. (1981). In vivo activity of purified mouse brain renin. Brain Research. 219(2). 371–384. 17 indexed citations

17.

Fuxé, Kjell, et al.. (1980). Evidence for differential localization of angiotensin‐l converting enzyme and renin in the corpus striatum of rat. Acta Physiologica Scandinavica. 110(3). 321–323. 19 indexed citations

18.

Schelling, P., Detlev Ganten, G. Speck, & Hans Fischer. (1979). Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cells. Journal of Cellular Physiology. 98(3). 503–513. 62 indexed citations

19.

Ganten, Detlev & G. Speck. (1978). The brain renin-angiotensin system: A model for the synthesis of peptides in the brain. Biochemical Pharmacology. 27(20). 2379–2389. 121 indexed citations

20.

Rettig, Rainer, et al.. (1978). In vivo enzyme activity of purified human brain renin. Journal of Molecular Medicine. 56(S1). 43–45. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact